Ikena Oncology: Funding, Investors & Team (Oct 2026)
Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.
Ikena Oncology has raised $115M across 2 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Dec 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ikena Oncology Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Ikena Oncology Funding Rounds
Ikena Oncology raised $40.0M in an undisclosed round announced in May 2023.
1.6 years later, an undisclosed round of $75.0M was announced in Dec 2024.
Ikena Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Ikena Oncology Funding Compared to Other Biotechnology Startups
Ikena Oncology's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ikena Oncology in Biotechnology and Boston
Companies Similar to Ikena Oncology
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Ikena Oncology Funding FAQs
What does Ikena Oncology do?
Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.
How much funding has Ikena Oncology raised?
Ikena Oncology has raised $115M across 2 rounds on record. The most recent is an undisclosed round of $75.0M announced in Dec 2024.
When did Ikena Oncology last raise funding?
Ikena Oncology's most recent funding round on record is an undisclosed round of $75.0M, announced in Dec 2024.
Who founded Ikena Oncology?
FundedIQ lists Karen Mcgovern (Founder) at Ikena Oncology.
Where is Ikena Oncology headquartered?
Ikena Oncology is based in Boston, Massachusetts, United States.
How many employees does Ikena Oncology have?
Ikena Oncology is in the 101-250 employee band.
How does Ikena Oncology's funding compare to other Biotechnology startups?
Ikena Oncology's latest round of $75.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ikena Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ikena Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.